Rak przełyku
Zapobieganie i profilaktyka

Rak przełyku, charakteryzujący się niskim pięcioletnim przeżyciem około 20%, występuje głównie w dwóch typach histologicznych: raku płaskonabłonkowym (SCC) i gruczolakoraku (EAC), które różnią się czynnikami ryzyka i wymagają odmiennych strategii profilaktycznych. Do kluczowych czynników ryzyka SCC należą palenie tytoniu (wszystkie formy), nadmierne spożycie alkoholu, ich synergistyczne działanie, żucie betelu, picie bardzo gorących napojów oraz dieta uboga w owoce i warzywa, a bogata w przetworzone mięso. W przypadku EAC dominują refluks żołądkowo-przełykowy (GERD), przełyk Barretta, otyłość brzuszna, palenie tytoniu, stosowanie leków rozluźniających dolny zwieracz przełyku oraz dieta. Profilaktyka pierwotna opiera się na eliminacji tych czynników, w tym zaprzestaniu palenia, ograniczeniu alkoholu do maksymalnie 2 standardowych porcji tygodniowo, unikaniu bardzo gorących napojów oraz modyfikacji diety i stylu życia. Leczenie GERD z zastosowaniem inhibitorów pompy protonowej (IPP) może zmniejszyć ryzyko progresji do przełyku Barretta i raka, wykazując redukcję ryzyka progresji nowotworowej o 75% u pacjentów z przełykiem Barretta.

Profilaktyka raka przełyku – wprowadzenie

Rak przełyku jest jednym z najbardziej śmiertelnych nowotworów, z pięcioletnim przeżyciem wynoszącym zaledwie około 20%. W ostatnich dekadach obserwuje się wzrost zachorowalności na ten nowotwór w wielu krajach świata. Nowotwór przełyku występuje w dwóch głównych typach histologicznych: rak płaskonabłonkowy (squamous cell carcinoma, SCC) i gruczolakorak (adenocarcinoma, EAC), które różnią się czynnikami ryzyka i wymagają odmiennych strategii profilaktycznych.12

Chociaż zidentyfikowano kilka istotnych czynników ryzyka, nadal brakuje skutecznych, opartych na dowodach naukowych strategii profilaktycznych. Skuteczne działania zapobiegawcze są kluczowe dla poprawy rokowania pacjentów z rakiem przełyku. Profilaktyka obejmuje unikanie czynników ryzyka oraz zwiększanie czynników ochronnych, co może pomóc zapobiec rozwojowi nowotworu.23

Czynniki ryzyka raka przełyku

Czynniki ryzyka raka płaskonabłonkowego przełyku

Rak płaskonabłonkowy przełyku jest związany z następującymi czynnikami ryzyka:12

  • Palenie tytoniu – wszystkie formy używania tytoniu (papierosy, cygara, fajki, tytoń do żucia) znacząco zwiększają ryzyko34
  • Spożywanie alkoholu – zwłaszcza nadmierne i długotrwałe34
  • Połączenie palenia tytoniu i spożywania alkoholu – zwiększa ryzyko w sposób synergistyczny5
  • Żucie betelu lub orzechów areki4
  • Picie bardzo gorących napojów (kawa, herbata, mate)6
  • Dieta uboga w owoce i warzywa6
  • Dieta bogata w przetworzone mięso6
  • Zakażenie niektórymi typami wirusa brodawczaka ludzkiego (HPV)7

Czynniki ryzyka gruczolakoraka przełyku

Gruczolakorak przełyku jest związany z następującymi czynnikami ryzyka:18

  • Refluks żołądkowo-przełykowy (GERD) – szczególnie gdy jest długotrwały i występują ciężkie, codzienne objawy910
  • Przełyk Barrettastan przedrakowy będący powikłaniem długotrwałego refluksu118
  • Otyłość brzuszna8
  • Palenie tytoniu8
  • Stosowanie leków rozluźniających dolny zwieracz przełyku8
  • Dieta uboga w warzywa i owoce, a bogata w przetworzone mięso8
  • Achalazja przełyku7

Strategie profilaktyczne w raku przełyku

Unikanie czynników ryzyka

Eliminacja czynników ryzyka jest podstawą profilaktyki pierwotnej raka przełyku:125

  • Zaprzestanie palenia tytoniu – unikanie wszystkich form tytoniu może znacząco zmniejszyć ryzyko raka płaskonabłonkowego przełyku. W krajach zachodnich, jak Stany Zjednoczone, palenie tytoniu i picie alkoholu mogą odpowiadać za około 90% przypadków raka płaskonabłonkowego przełyku.1310
  • Ograniczenie spożycia alkoholu – najlepiej całkowite unikanie alkoholu lub ograniczenie do maksymalnie 2 standardowych porcji tygodniowo. Połączenie palenia tytoniu i spożywania alkoholu stanowi szczególnie wysokie ryzyko.45
  • Unikanie bardzo gorących napojów – picie bardzo gorących napojów, jak kawa czy herbata, zwiększa ryzyko raka przełyku.6

Dieta i styl życia

Modyfikacja diety i stylu życia może znacząco zmniejszyć ryzyko raka przełyku:57

  • Zdrowa dieta bogata w owoce i warzywa – szczególnie warzywa krzyżowe (kapusta, kalafior) zawierające substancje, które mogą pomóc zapobiegać rakowi przełyku76
  • Ograniczenie spożycia przetworzonego mięsa6
  • Utrzymanie prawidłowej masy ciała – otyłość wiąże się ze zwiększonym ryzykiem gruczolakoraka przełyku54
  • Regularna aktywność fizyczna – może zmniejszyć ryzyko raka przełyku, szczególnie gruczolakoraka1415

Leczenie chorób predysponujących

Odpowiednie leczenie stanów predysponujących może zapobiec rozwojowi raka przełyku:1617

  • Leczenie refluksu żołądkowo-przełykowego (GERD) – stosowanie inhibitorów pompy protonowej (PPI) może zmniejszyć ryzyko progresji do przełyku Barretta i raka. Badania wykazały, że stosowanie PPI wiąże się z 75% redukcją ryzyka progresji nowotworowej u pacjentów z przełykiem Barretta.1819
  • Monitorowanie i leczenie przełyku Barretta – regularne badania endoskopowe u pacjentów z przełykiem Barretta mogą pomóc w wykryciu dysplazji i wczesnego raka1620
  • Leczenie achalazji przełyku – dostępnych jest kilka metod leczenia, w tym leki, iniekcje i zabiegi chirurgiczne7

Chemioprofilaktyka w raku przełyku

Chemioprofilaktyka to stosowanie leków, witamin lub innych substancji w celu zmniejszenia ryzyka rozwoju nowotworu. W przypadku raka przełyku badano kilka strategii chemioprofilaktycznych:913

Niesteroidowe leki przeciwzapalne (NLPZ)

Badania epidemiologiczne wykazały, że stosowanie aspiryny lub innych NLPZ może być związane ze zmniejszonym ryzykiem rozwoju lub zgonu z powodu raka przełyku (iloraz szans [OR], 0,57; 95% przedział ufności [CI], 0,47-0,71).1310

Mimo to, ze względu na znane działania niepożądane NLPZ, w tym krwawienia z górnego odcinka przewodu pokarmowego i poważne zdarzenia sercowo-naczyniowe (zawał mięśnia sercowego, niewydolność serca, udar krwotoczny i uszkodzenie nerek), większość lekarzy nie zaleca stosowania NLPZ wyłącznie w celu zapobiegania rakowi przełyku.1621

Inhibitory pompy protonowej (IPP)

Stosowanie inhibitorów pompy protonowej (IPP) jest zalecane u pacjentów z przełykiem Barretta. Badania sugerują, że IPP mogą zmniejszać ryzyko progresji nowotworowej:2218

  • Wieloośrodkowe prospektywne badanie kohortowe wykazało, że stosowanie IPP wiązało się z 75% redukcją ryzyka progresji nowotworowej u pacjentów z przełykiem Barretta18
  • Wytyczne kliniczne zalecają, aby pacjenci z przełykiem Barretta otrzymywali IPP raz dziennie2318
  • Badanie AspECT analizujące stosowanie ezomeprazolu i aspiryny w chemioprofilaktyce przełyku Barretta wykazało korzystne działanie prewencyjne2425

Statyny

Istnieją pewne dane sugerujące, że statyny mogą odgrywać rolę w chemioprofilaktyce raka przełyku:26

  • Badania wykazały, że statyny zmniejszają progresję zmian prekursorowych do dysplazji wysokiego stopnia lub gruczolakoraka przełyku o 48%26
  • Potrzebne są jednak dodatkowe badania, aby określić korzyści ze stosowania statyn w profilaktyce raka przełyku27

Endoskopowe metody zapobiegania rakowi przełyku

Nadzór endoskopowy

Regularne badania endoskopowe są zalecane dla osób z podwyższonym ryzykiem raka przełyku, szczególnie u pacjentów z przełykiem Barretta:1620

  • Pacjenci z przełykiem Barretta bez dysplazji powinni przechodzić endoskopię kontrolną co 3-5 lat20
  • Pacjenci z dysplazją niskiego stopnia wymagają częstszych kontroli16
  • Pacjenci z dysplazją wysokiego stopnia powinni być ściśle monitorowani i rozważana powinna być interwencja terapeutyczna16

Ablacja radioczęstotliwościowa

Ablacja radioczęstotliwościowa (RFA) może prowadzić do eradykacji dysplazji i metaplazji jelitowej oraz zmniejszenia ryzyka progresji choroby:1322

  • Randomizowane badanie kontrolowane wykazało, że ablacja radioczęstotliwościowa przełyku Barretta z ciężką dysplazją może prowadzić do eradykacji zarówno dysplazji, jak i metaplazji jelitowej oraz zmniejszonego ryzyka progresji choroby1013
  • Pacjenci z przełykiem Barretta, u których występują nieprawidłowe komórki w dolnym przełyku, mogą być leczeni za pomocą ablacji radioczęstotliwościowej28
  • Procedura wykorzystuje fale radiowe do ogrzewania i niszczenia nieprawidłowych komórek, które mogą przekształcić się w komórki nowotworowe28

Resekcja błony śluzowej

Techniki resekcji błony śluzowej, w których tkanka jest wycinana, są bardzo skuteczne we wczesnym stadium raka, gdy wykonywane są w doświadczonych ośrodkach.20 Metoda ta pozwala na usunięcie zmian przedrakowych i wczesnych zmian nowotworowych, zapobiegając ich dalszej progresji.19

Nowe metody diagnostyczne w profilaktyce raka przełyku

Rozwój nowych metod diagnostycznych może poprawić wczesne wykrywanie i zapobieganie rakowi przełyku:829

Cytosponge

Cytosponge to nieinwazyjna metoda diagnostyczna do wykrywania przełyku Barretta:829

  • Jest to kapsułka przymocowana do sznurka zawierająca gąbkę, którą pacjent połyka
  • Po rozpuszczeniu żelatyny w żołądku, gąbka jest wyciągana wzdłuż przełyku, zbierając komórki
  • Cytosponge jest połączony z TFF3, immunohistochemicznym biomarkerem dla nabłonka Barretta
  • Metoda ta może być wykorzystywana do nieinwazyjnego badania przesiewowego w kierunku przełyku Barretta829

Technologia WATS3D

WATS3D to przełomowa procedura endoskopowa, która pomaga lekarzowi wykryć komórki przedrakowe:30

  • Umożliwia pobranie większej ilości tkanki zagrożonej przekształceniem w nowotwór
  • Pobiera próbki z głębszych warstw wyściółki przełyku
  • Wykorzystuje zaawansowaną analizę komputerową, sztuczną inteligencję i zastrzeżone obrazowanie 3D
  • Pomaga patologom identyfikować komórki przedrakowe z większą dokładnością i spójnością30

Badania kliniczne w profilaktyce raka przełyku

Kliniczne badania nad zapobieganiem nowotworom są wykorzystywane do badania sposobów zapobiegania rakowi przełyku.31 Nowe metody zapobiegania rakowi przełyku są badane w badaniach klinicznych, w tym:32

  • Nowe strategie chemioprofilaktyczne33
  • Udoskonalone metody diagnostyczne29
  • Optymalizacja protokołów nadzoru endoskopowego18
  • Nowe interwencje w zakresie stylu życia34

Indywidualizacja działań profilaktycznych

Kluczową strategią w profilaktyce raka przełyku jest identyfikacja osób z wysokim ryzykiem i dostosowanie interwencji profilaktycznych do indywidualnych potrzeb:835

  • Ocena czynników ryzyka, takich jak palenie tytoniu, spożywanie alkoholu, GERD, przełyk Barretta8
  • Opracowanie spersonalizowanego planu profilaktyki35
  • Zalecenia mogą obejmować:
    • Regularny nadzór endoskopowy
    • Zmiany w stylu życia i diecie
    • Farmakoterapię (IPP, potencjalnie NLPZ lub statyny)
    • Testy genetyczne w wybranych przypadkach35

Zintegrowane podejście do profilaktyki raka przełyku

Skuteczna profilaktyka raka przełyku wymaga kompleksowego podejścia, które obejmuje:3623

Profilaktyka pierwotna: identyfikacja i eliminacja czynników ryzyka, w tym:3637

  • Zaprzestanie palenia tytoniu
  • Ograniczenie spożycia alkoholu
  • Utrzymanie prawidłowej masy ciała
  • Zdrowa dieta bogata w owoce i warzywa
  • Regularna aktywność fizyczna1238

Profilaktyka wtórna: wykrywanie zmian przedrakowych i wczesnych zmian nowotworowych, gdy leczenie endoskopowe jest nadal możliwe:36

  • Regularne badania endoskopowe u osób z czynnikami ryzyka
  • Leczenie GERD i przełyku Barretta
  • Ablacja radioczęstotliwościowa lub resekcja błony śluzowej w przypadku wykrycia dysplazji3623

Profilaktyka trzeciorzędowa: przydzielanie zasobów endoskopowych pacjentom, u których zidentyfikowano już stany przedrakowe lub wczesny rak lub którzy byli leczeni:23

  • Protokoły nadzoru endoskopowego rozpoczynające się po leczeniu
  • Kontynuacja co 6 miesięcy przez 3-10 lat, a następnie badania coroczne2318

Kompleksowe, wielopoziomowe podejście do profilaktyki raka przełyku, obejmujące unikanie czynników ryzyka, regularne badania przesiewowe osób z grupy wysokiego ryzyka oraz odpowiednie leczenie stanów przedrakowych, stanowi najlepszą strategię zmniejszenia zachorowalności i śmiertelności związanej z tym nowotworem.3623

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 16.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8125297/
    In the last decades, there has been a rapid increase in the incidence and prevalence of esophageal cancer in many countries around the world. […] Although several important risk factors have been identified, strong evidence-based preventive strategies are still lacking, and the prognosis of patients diagnosed with esophageal cancer remains poor, with an average survival rate of 5 years for only 20%. […] This review provides a summary of the epidemiological features and risk factors associated with these tumors. Moreover, a major focus is posed on reporting and highlighting the various preventing strategies proposed by the most important international scientific societies, particularly in high-risk populations, with the final aim of detecting these lesions as early as possible and therefore favoring their definite cure.
  • #1 Esophageal Cancer Prevention – NCI
    https://www.cancer.gov/types/esophageal/patient/esophageal-prevention-pdq
    Avoiding risk factors and increasing protective factors may help prevent cancer. […] The following risk factors increase the risk of squamous cell carcinoma of the esophagus: Smoking and alcohol use. […] The following protective factors may decrease the risk of squamous cell carcinoma of the esophagus: Avoiding tobacco and alcohol use, Chemoprevention with nonsteroidal anti-inflammatory drugs. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. […] The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs, Radiofrequency ablation of the esophagus. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #2 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://www.mdpi.com/2072-6694/13/9/2183
    In the last decades, there has been a rapid increase in the incidence and prevalence of esophageal cancer in many countries around the world. […] Although several important risk factors have been identified, strong evidence-based preventive strategies are still lacking, and the prognosis of patients diagnosed with esophageal cancer remains poor, with an average survival rate of 5 years for only 20%. […] This review is an attempt to summarize the epidemiology and risk factors of EC and to highlight the unresolved aspects of current prevention strategies in order to plan more fruitful future initiatives aimed at ameliorating the disappointing prognosis of this kind of digestive tumor. […] This review provides a summary of the epidemiological features and risk factors associated with these tumors. Moreover, a major focus is posed on reporting and highlighting the various preventing strategies proposed by the most important international scientific societies, particularly in high-risk populations, with the final aim of detecting these lesions as early as possible and therefore favoring their definite cure.
  • #2 Esophageal Cancer Prevention | Reducing Esophageal Cancer Risk in Cleveland, OH | University Hospitals
    https://www.uhhospitals.org/services/cancer-services/thoracic-and-esophageal-cancer/esophageal-cancer/prevention
    Avoiding risk factors and increasing protective factors may help prevent cancer. […] The following risk factors increase the risk of squamous cell carcinoma of the esophagus: Smoking and alcohol use. […] The following protective factors may decrease the risk of squamous cell carcinoma of the esophagus: Avoiding tobacco and alcohol use. […] Chemoprevention with nonsteroidal anti-inflammatory drugs. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. […] The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs. […] Radiofrequency ablation of the esophagus. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #3 Esophageal Cancer Prevention – NCI
    https://www.cancer.gov/types/esophageal/patient/esophageal-prevention-pdq
    Avoiding risk factors and increasing protective factors may help prevent cancer. […] The following risk factors increase the risk of squamous cell carcinoma of the esophagus: Smoking and alcohol use. […] The following protective factors may decrease the risk of squamous cell carcinoma of the esophagus: Avoiding tobacco and alcohol use, Chemoprevention with nonsteroidal anti-inflammatory drugs. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. […] The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs, Radiofrequency ablation of the esophagus. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #3 Preventing Esophageal Cancer | NYU Langone Health
    https://nyulangone.org/conditions/esophageal-cancer/prevention
    Cancer of the esophagus, the muscular tube that carries food to the stomach, is largely preventable. There are two types of the condition: squamous cell carcinoma, which develops in the flat cells that line the esophagus, and adenocarcinoma, which arises in gland cells. In the United States, esophageal adenocarcinoma is more common than squamous cell carcinoma. […] NYU Langone doctors recommend several actions you can take to reduce the likelihood of getting esophageal cancer. […] Smoking increases the risk of esophageal cancer, especially squamous cell carcinoma. If you smoke, doctors strongly urge you to quit. You can get help quitting through the comprehensive Tobacco Cessation Programs at NYU Langone. […] Heavy alcohol consumption increases the risk of squamous cell esophageal cancer. Alcohol is recognized as a human carcinogen, and can damage the lining of the esophagus over time. Moderate alcohol intake is defined as no more than two drinks per day in men and one drink in women.
  • #4 Reducing your risk for esophageal cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/esophageal/risks/reducing-your-risk
    You may lower your risk of developing esophageal cancer by doing the following. […] The best way to lower your risk for esophageal cancer is to avoid all forms of tobacco, including cigarettes, cigars, pipes and smokeless tobacco. […] Quitting reduces your risk of esophageal cancer. […] Drinking alcohol increases your risk of developing esophageal cancer. […] To reduce your cancer risk, it’s best not to drink alcohol. […] If you choose to drink alcohol, keep your cancer risk as low as possible by having no more than 2 standard drinks a week. […] Not chewing betel quid or areca nut lowers your risk of developing esophageal cancer. […] GERD is a disorder in which the contents of the stomach (including stomach acid) back up, or reflux, into the esophagus. […] Research shows that being overweight or obese increases your risk of adenocarcinoma of the esophagus.
  • #5 Can Esophageal Cancer Be Prevented? | Preventing Esophagus Cancer | American Cancer Society
    https://www.cancer.org/cancer/types/esophagus-cancer/causes-risks-prevention/prevention.html
    Avoid tobacco and alcohol […] Watch your diet, body weight, and physical activity […] Get treated for reflux or Barretts esophagus […] Not all esophageal cancers can be prevented, but the risk of developing this disease can be greatly reduced by avoiding certain risk factors. […] In the United States, the most important lifestyle risk factors for cancer of the esophagus are the use of tobacco and alcohol. Each of these factors alone increases the risk of esophageal cancer many times, and the risk is even greater if they are combined. Avoiding tobacco and alcohol is one of the best ways of limiting your risk of esophageal cancer. […] Following a healthy eating pattern and staying at a healthy weight are also important. A diet rich in fruits and vegetables may help lower esophageal cancer risk. Obesity has been linked with esophageal cancer, particularly the adenocarcinoma type, so staying at a healthy weight may also help limit the risk of this disease. Being physically active may also reduce your risk of esophageal cancer.
  • #6 Reducing your risk for esophageal cancer | Canadian Cancer Society
    https://cancer.ca/en/cancer-information/cancer-types/esophageal/risks/reducing-your-risk
    You can lower your risk by having a healthy body weight. […] Drinking very hot beverages, such as hot coffee, tea and mat, increases your risk of esophageal cancer. […] Diets that are high in processed meats may increase the risk of developing squamous cell carcinoma (SCC) of the esophagus. […] There is some evidence that eating a healthy diet that includes lots of vegetables and fruit may lower your risk of developing esophageal cancer. […] Studies have shown that physical activity may lower the risk of esophageal cancer. […] If you are at higher than average risk, you may need to visit your doctor more often to check for esophageal cancer.
  • #7 Preventing Esophageal Cancer | NYU Langone Health
    https://nyulangone.org/conditions/esophageal-cancer/prevention
    If you have gastroesophageal reflux disease, or GERD, in which acidic stomach contents rise into the esophagus two or more times a week, you have a slightly increased risk of esophageal adenocarcinoma. […] If you are overweight or obese, talk with your doctor or a dietitian about the best way to slim down. Experts in our Weight Management Program can also help. […] Eating a diet rich in fruits and vegetables may help you lose weight. Such a diet can also help reduce your risk of developing esophageal squamous cell carcinoma. Some studies show that cruciferous vegetables, such as cauliflower and cabbage, contain substances that may help prevent esophageal cancer. […] Infection with certain types of human papillomavirus, or HPV, a common sexually transmitted disease, can increase your chance of developing squamous cell cancer. […] People with achalasia have an increased long-term risk of developing esophageal cancer. There are several treatments for achalasia, including medication, injections, and surgery.
  • #8 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8125297/
    In order to achieve a major improvement in the prognosis of EC, preventive measures have been investigated, developed, and are highly warranted. […] The identification of risk factors is an important first step for primary prevention. […] The major risk factors for EAC include symptomatic gastro-esophageal reflux disease (GERD), Barretts esophagus, visceral abdominal obesity, tobacco use, assumption of drugs that relax the lower esophageal sphincter, as well as diet with a low intake of vegetables and fruit and rich in processed meat. […] It is of fundamental importance to identify high-risk groups for ESCC and EAC in order to detect premalignant lesions early and offer them adequate monitoring. […] The cytosponge is coupled with TFF3, an immunohistochemical biomarker for Barretts epithelium within a capsule attached to a string that must be swallowed and, when gelatin dissolves inside the stomach, the sponge is pulled up along the esophagus for cell collection.
  • #9 Esophageal Cancer Prevention (PDQ®): Prevention – Patient Information [NCI] | Cigna
    https://www.cigna.com/knowledge-center/hw/medical-topics/esophageal-cancer-prevention-ncicdr0000062888
    Chemoprevention with nonsteroidal anti-inflammatory drugs. Chemoprevention is the use of drugs, vitamins, or other substances to help lower a person’s risk of developing cancer. Nonsteroidal anti-inflammatory drugs (NSAIDs) include aspirin and other drugs that reduce swelling and pain. Some studies have shown that the use of NSAIDs may lower the risk of squamous cell carcinoma of the esophagus. However, the use of NSAIDs increases the risk of heart attack, heart failure, stroke, bleeding in the stomach and intestines, and kidney damage. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. Adenocarcinoma of the esophagus is strongly linked to gastroesophageal reflux disease (GERD), especially when the GERD lasts a long time and severe symptoms occur daily.
  • #10 Esophageal Cancer Prevention (PDQ®): Prevention – Health Professional Information [NCI] | Kaiser Permanente
    https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.esophageal-cancer-prevention-pdq%C2%AE-prevention-health-professional-information-nci.ncicdr0000062880
    Smoking and drinking alcohol may account for roughly 90% of esophageal squamous cell carcinoma cases in Western countries like the United States. […] Based on solid evidence, avoidance of tobacco and alcohol would decrease the risk of squamous cell carcinoma. […] Based on fair evidence, epidemiological studies have found that aspirin or NSAID use is associated with decreased risk of developing or dying from esophageal cancer (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.470.71). […] Based on fair evidence, an association exists between GERD and adenocarcinoma, particularly if the GERD is long-standing and symptoms are severe. […] Based on fair evidence, epidemiological studies have found that aspirin or NSAID use is associated with decreased risk of developing or dying from esophageal cancer (OR, 0.57; 95% CI, 0.470.71). […] A randomized controlled trial has found that radiofrequency ablation of Barrett esophagus with severe dysplasia may lead to eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression.
  • #11 Esophageal Cancer Prevention and Risk Factors
    https://www.johnmuirhealth.com/services/cancer-services/what-we-treat/esophageal-cancer-services/esophageal-cancer-prevention.html
    While there is not a standard screening test for esophageal cancer and the exact cause may not be fully understood, there are certain modifiable and non-modifiable risks factors and esophageal conditions that are associated with a higher incidence of diagnosis of esophageal cancer. […] The most common risks factors include: […] Tobacco and alcohol use: Use of tobacco in any form can increase your risk of developing esophageal cancer, particularly squamous cell carcinoma. The same is true of heavy use of alcohol over a long period of time. […] Barretts esophagus: This condition happens when long-term reflux of acid from the stomach into the esophagus causes precancerous changes in the cells of the esophagus. A diagnosis of Barretts esophagus increases the risk of esophageal adenocarcinoma.
  • #12
    https://winshipcancer.emory.edu/cancer-types-and-treatments/esophageal-cancer/prevention.php
    There are two main types of esophageal cancer, both of which can be prevented. […] This is why its so important to prevent esophageal cancer. The first step is understanding what causes esophageal cancer. […] Because many esophageal cancers are preventable, it is possible to reduce your risk through lifestyle changes. […] NCI recommends the following esophageal cancer prevention guidelines: Not using any tobacco products, Not consuming alcohol, Maintaining a body mass index below 25, Being physically active every day, Eating a diet rich in fruits and vegetables and low in processed meats, Seeking treatment for reflux disease and Barrett esophagus. […] While many esophageal cancers can be avoided by abstaining from tobacco or alcohol, some cannot.
  • #13 Esophageal Cancer Prevention (PDQ®) – NCI
    https://www.cancer.gov/types/esophageal/hp/esophageal-prevention-pdq
    Smoking and drinking alcohol may account for roughly 90% of esophageal squamous cell carcinoma cases in Western countries like the United States. […] Based on solid evidence, avoidance of tobacco and alcohol would decrease the risk of squamous cell carcinoma. […] Based on fair evidence, epidemiological studies have found that aspirin or NSAID use is associated with decreased risk of developing or dying of esophageal cancer (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.470.71). […] Based on fair evidence, epidemiological studies have found that aspirin or NSAID use is associated with decreased risk of developing or dying from esophageal cancer (OR, 0.57; 95% CI, 0.470.71). […] A randomized controlled trial has found that radiofrequency ablation of Barrett esophagus with severe dysplasia may lead to eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression. […] This study suggests that the treatment of patients with Barrett esophagus and dysplasia may ablate Barrett esophagus and prevent disease progression.
  • #14 Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-14-101
    Physical activity has been inversely associated with risk of several cancers. […] Meta-analysis of published observational studies indicates that physical activity may be associated with reduced risk of esophageal adenocarcinoma. Lifestyle interventions focusing on increasing physical activity may decrease the global burden of EAC. […] For non-tobacco users, diet and physical activity are the most important modifiable determinants of cancer risk. […] The protective effect of physical activity against cancer is possibly mediated by counteracting the adverse carcinogenic effects of obesity, improving insulin sensitivity and decreasing systemic inflammation leading to favorable immunomodulation. […] There have been several studies reporting an inverse association between physical activity and risk of esophageal cancer, but results have been inconsistent.
  • #15 Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-14-101
    To better understand the relationship between physical activity and esophageal cancer risk, in particular, the risk of EAC, we performed a systematic review with meta-analysis of all studies that investigated the association between physical activity and risk of esophageal cancer in adults. […] The primary analysis focused on assessing the association between physical activity and the risk of overall esophageal cancer, as well as by histological subtypes EAC and ESCC. […] On sub-group analysis, the association between physical activity and risk of esophageal cancer was stable across case-control and cohort studies, and across Western and Asian population. […] Recreational physical activity, the potentially modifiable component of physical activity, was associated with a decreased risk of esophageal cancer.
  • #16 Can Esophageal Cancer Be Prevented? | Preventing Esophagus Cancer | American Cancer Society
    https://www.cancer.org/cancer/types/esophagus-cancer/causes-risks-prevention/prevention.html
    Treating people with reflux may help prevent Barretts esophagus and esophageal cancer. […] People at a higher risk for esophageal cancer, such as those with Barretts esophagus, are often watched closely by their doctors with endoscopies to look for signs that the cells lining the esophagus have become more abnormal. […] If dysplasia (a pre-cancerous condition) is found, the doctor may recommend treatments to keep it from developing into esophageal cancer. […] For those who have Barretts esophagus, daily treatment with a PPI might lower the risk of developing cell changes (dysplasia) that can turn into cancer. […] Treatment can often improve symptoms and might prevent future problems. […] Some studies have found that the risk of cancer of the esophagus is lower in people with Barretts esophagus who take aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen. […] For this reason, most doctors dont advise that people take NSAIDs to try to prevent esophageal cancer.
  • #17 Esophageal Cancer Prevention & Improved Treatment Options – OHC
    https://ohcare.com/esophageal-cancer-prevention/
    Taking steps to prevent cancer and understanding cancer risk factors are critical to well-being, particularly with cancers like esophageal cancer that are difficult to detect. […] While some risk factors are out of our control, there are steps you can take to decrease your risk of getting esophageal cancer. […] Not all esophageal cancers can be prevented, but there are ways to reduce your risk. According to the American Cancer Society, one of the best ways to protect yourself is to avoid tobacco and alcohol. Maintain a healthy lifestyle by having a healthy weight. Stay physically active and eat a healthy diet rich in fruits and vegetables. […] If you have frequent heartburn, speak to your doctor about acid reflux or GERD and ways to control the condition. Suffering with reflux for a long time can lead to Barrett’s esophagus, damage to the inner lining of the esophagus that increases your cancer risk.
  • #18 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://www.mdpi.com/2072-6694/13/9/2183
    The proposed and recommended endoscopy surveillance protocols usually start after curative treatment for head and neck cancer and continue every 6 months for 3–10 years to annual examinations. […] The main lifestyle and clinical factors known to influence the development of esophageal cancer and the related international recommendations are reported in Table 2. […] The clinical guidelines reported above recommend that patients with BE should receive once-daily PPI therapy. […] A multicenter prospective cohort study demonstrated that PPI use was associated with a 75% reduction in the risk of neoplastic progression in patients with BE. […] The use of these chemo-preventive agents, due to their well-known adverse effects such as cerebral and GI hemorrhage, is not justified also considering that the estimated risk of progression in patients with non-dysplastic BE is low (0.1–0.5%/year).
  • #19
    https://link.springer.com/article/10.1007/s11864-004-0030-6
    Early esophageal cancer is defined by its limitation to the esophageal mucosa and submucosa. Understanding the risk factors, establishing surveillance programs for patients at risk, and developing preventative interventions such as dietary and lifestyle changes or pharmacologic interventions hold the potential of reducing the incidence of the disease and of shifting the stage distribution toward early cancer. […] New, less invasive surgical techniques are being tested that are associated with less morbidity and mortality than standard radical esophagectomies. […] For patients who are not candidates for surgery, definitive chemoradiation is a viable alternative. […] New endoscopic ablation techniques, such as endoscopic mucosa resection and photodynamic therapy, are potential alternatives to surgery in patients with cancers limited to the mucosa. […] For patients with adenocarcinoma of the gastroesophageal junction with submucosal involvement, adjuvant chemoradiation should be considered because of its potential to increase survival.
  • #20 Esophageal Cancer Prevention – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/december-2016/esophageal-cancer-prevention/
    The most recent guidelines published by the American College of Gastroenterology, the American Gastroenterological Association, and the British Society of Gastroenterology advocate selective screening, which had not previously been recommended. […] The guidelines usually recommend surveillance endoscopy every 3 to 5 years, with 3 years being the most common interval for patients with nondysplastic Barrett esophagus. […] Mucosal resection techniques, in which the tissue is cut or shaved off, are very effective for early-stage cancer when performed in experienced centers. […] Recurrence is a major concern if the cancer was deep. […] One of the top priorities is to develop an effective screening program. […] We also need better research to help define the patient populations that require therapy.
  • #21 Esophageal Cancer Prevention (PDQ®): Prevention – Health Professional Information [NCI] Arlington, VA
    https://nvpwomen.com/womens-health/healthwise?DOCHWID=ncicdr0000062880
    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER. […] Smoking and drinking alcohol may account for roughly 90% of esophageal squamous cell carcinoma cases in Western countries like the United States. […] Based on solid evidence, avoidance of tobacco and alcohol would decrease the risk of squamous cell carcinoma. […] Based on fair evidence, epidemiological studies have found that aspirin or NSAID use is associated with decreased risk of developing or dying from esophageal cancer (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.47–0.71). […] Based on solid evidence, harms of NSAID use include upper gastrointestinal bleeding and serious cardiovascular events, such as myocardial infarction, heart failure, hemorrhagic stroke, and renal impairment.
  • #22 Screening and prevention strategies and endoscopic management of early esophageal cancer – Kim – Chinese Clinical Oncology
    https://cco.amegroups.org/article/view/17141/html
    Esophageal cancer is the 8th most common cancer worldwide and the 6th most common cause of cancer-related death. […] Preventive strategies involving reduction in tobacco and alcohol consumption as well as regular use of proton pump inhibitors and nonsteroidal anti-inflammatory drugs are aimed at reducing the incidence of dysplasia and esophageal cancer, but require further study before being recommended for widespread use. […] In addition to lifestyle interventions such as smoking cessation and alcohol abstinence, chemopreventive strategies involving PPIs, non-steroidal anti-inflammatory drugs (NSAIDs), and statins have been examined. […] As a result, it is currently recommended that patients with BE adhere to daily PPI therapy. […] Aspirin and NSAID use has been examined in the chemoprevention of ESCC as well, but the role of COX-2 expression in the pathogenesis of ESCC is less clear.
  • #23 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8125297/
    The proposed and recommended endoscopy surveillance protocols usually start after curative treatment for head and neck cancer and continue every 6 months for 3-10 years to annual examinations. […] The clinical guidelines reported above recommend that patients with BE should receive once-daily PPI therapy. […] The use of PPIs is associated with a decreased risk of esophageal adenocarcinoma and/or BE with high dysplasia in BE patients. […] In conclusion, the primary means of prevention for EAC and ESCC is to identify the risk factors and, if present, eliminate them. […] The secondary prevention consists of the detection of precancerous and early cancerous lesions when curative endoscopic treatment is still possible. […] The tertiary means of prevention is to allocate endoscopic resources to subjects in whom precancerous or early cancer conditions have already been identified or treated.
  • #24 Chemoprevention Reduces Risk for Esophageal Cancer
    https://www.onclive.com/view/chemoprevention-reduces-risk-for-esophageal-cancer
    A combination of 2 over-the-counter medicines can moderately reduce the risk for high-grade dysplasia or esophageal cancer in patients with Barretts esophagus if taken for at least 7 years. […] The use of esomeprazole, a proton pump inhibitor (PPI) that suppresses gastric acid, at a high dose (40 mg twice daily) in combination with low-dose aspirin was the most effective of 4 chemoprevention strategies involving the PPI and aspirin that researchers from the United Kingdom evaluated in a study that was launched nearly 20 years ago. […] The hazard ratio in favor of PPI use is 0.80 (P = .037), lead study author Janusz Jankowski, MD, MBBS, said while discussing the results during a press conference. […] Patients with Barretts, specifically, should speak with their physician about taking these drugs together in order to delay the events studied in this trial. […] Richard L. Schilsky, MD, ASCO senior vice president and chief medical officer, noted that Barretts can only be diagnosed with an endoscopy. Even if this type of treatment is appropriate, he said that patients require prospective monitoring to determine whether the lesion is shrinking.
  • #25 High dose of the acid-reducing medicine esomeprazole… – Oncology Central
    https://www.oncology-central.com/acid-reducing-medicine-esomeprazole/
    A Phase III randomized trial has demonstrated that taking a high dose of the acid-reducing medicine esomeprazole (Nexium) with low dose aspirin for a minimum of 7 years can reduce the risk of developing esophageal cancer, a pre-cancerous lesion termed high-grade dysplasia or delay death from any cause in people with Barretts esophagus. […] From their analysis, the researchers discovered that esomeprazole had the strongest effect on prevention of esophageal cancer. […] Collectively, the team have estimated that interventions prevented 2025% of esophageal cancers and for those individuals who did ultimately develop esophageal cancer; the treatments delayed the onset of esophageal cancer by 12 years. […] We hope that the National Institute for Health and Care Excellence in the UK and national bodies in other countries will consider our findings when developing guidelines for esophageal cancer prevention.
  • #26 Can Esophageal Cancer Be Prevented? | Blog | AACR
    https://www.aacr.org/blog/2020/04/02/how-can-we-reduce-the-risk-for-esophageal-cancer/
    One way to potentially prevent esophageal cancer is to avoid risky behaviors, such as smoking, and heavy drinking. […] A recent study found that physical activity plays a role in preventing many types of cancer, including esophageal cancer. There is some evidence that nonsteroidal anti-inflammatory drugs can provide protection against squamous cell carcinoma of the esophagus. […] In the study from Scientific Reports discussed above, the researchers found selective serotonin reuptake inhibitor drugs (SSRI) provided protection against neoplastic progression of Barretts esophagus. […] The study also found that statins reduced the progression of precursors to high-grade dysplasia or esophageal adenocarcinoma by 48 percent. […] The authors note that the utility of proton pump inhibitors would require further study.
  • #27 Screening and prevention strategies and endoscopic management of early esophageal cancer – Kim – Chinese Clinical Oncology
    https://cco.amegroups.org/article/view/17141/html
    Data regarding the benefits of aspirin and NSAIDs in the chemoprevention of esophageal cancer is mixed. […] There is a large, multicenter randomized controlled trial (AspECT) examining the use of aspirin and esomeprazole for chemoprevention in BE that has reached its target recruitment of 2,500 patients and is expected to publish its results in 2018. […] Additional studies are needed to determine the benefit of statins in the prevention of esophageal cancer.
  • #28 Esophageal Cancer Prevention (PDQ®): Prevention – Patient Information [NCI] | Cigna
    https://www.cigna.com/knowledge-center/hw/medical-topics/esophageal-cancer-prevention-ncicdr0000062888
    The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs. […] Radiofrequency ablation of the esophagus. Patients with Barrett esophagus who have abnormal cells in the lower esophagus may be treated with radiofrequency ablation. This procedure uses radio waves to heat and destroy abnormal cells, which may become cancer. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #29 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://www.mdpi.com/2072-6694/13/9/2183
    Indeed, we have conducted analysis with attention to the current primary, secondary and tertiary prevention guidelines in both ESCC and EAC, attempting to emphasize unresolved research and clinical problems related to these topics in order to improve our diagnostic strategies and management. […] The identification of risk factors is an important first step for primary prevention. […] In order to achieve a major improvement in the prognosis of EC, preventive measures have been investigated, developed, and are highly warranted. […] It is of fundamental importance to identify high-risk groups for ESCC and EAC in order to detect premalignant lesions early and offer them adequate monitoring. […] The cytosponge is coupled with TFF3, an immunohistochemical biomarker for Barrett’s epithelium within a capsule attached to a string that must be swallowed and, when gelatin dissolves inside the stomach, the sponge is pulled up along the esophagus for cell collection.
  • #30 Esophageal cancer prevention – WATS3D technology makes it possible
    https://www.prevea.com/resources/esophageal-cancer-prevention-wats3d-technology-makes-it-possible
    Most people dont associate chronic heartburn with esophageal cancer, and yet, if it goes unchecked, chronic heartburn can lead to Barrett’s esophagus, a precancerous condition of the esophagus. […] The good news is that due to recent medical advances in detection, theres a procedure that can help more accurately identify pre-cancer cells. Its called WATS3D, a breakthrough endoscopic procedure that helps your doctor detect pre-cancerous cells so they can be removed before they can turn into esophageal cancer. […] Benefits of the WATS3D method over traditional tissue sampling is sampling of a much greater amount of tissue that is at-risk for turning into cancer as well as samples from deeper layers of the esophageal lining. […] This WATS3D specimen is sent to the laboratory for advanced computer analysis that uses artificial intelligence and proprietary 3-D imaging to help pathologists identify pre-cancer cells with greater accuracy and consistency.
  • #31 Esophageal Cancer – Prevention
    https://ruesch.georgetown.edu/esophagealcancerprevention/
    Cancer prevention is action taken to lower the chance of getting cancer. By preventing cancer, the number of new cases of cancer in a group or population is lowered. Hopefully, this will lower the number of deaths caused by cancer. […] Avoiding risk factors and increasing protective factors may help prevent cancer. […] The following risk factors increase the risk of squamous cell carcinoma of the esophagus: Smoking and alcohol use. […] The following protective factors may decrease the risk of squamous cell carcinoma of the esophagus: Avoiding tobacco and alcohol use. […] Chemoprevention with nonsteroidal anti-inflammatory drugs. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. […] The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs. […] Radiofrequency ablation of the esophagus. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #32 Esophageal Cancer Prevention | Reducing Esophageal Cancer Risk in Cleveland, OH | University Hospitals
    https://www.uhhospitals.org/services/cancer-services/thoracic-and-esophageal-cancer/esophageal-cancer/prevention
    Avoiding risk factors and increasing protective factors may help prevent cancer. […] The following risk factors increase the risk of squamous cell carcinoma of the esophagus: Smoking and alcohol use. […] The following protective factors may decrease the risk of squamous cell carcinoma of the esophagus: Avoiding tobacco and alcohol use. […] Chemoprevention with nonsteroidal anti-inflammatory drugs. […] The following risk factors increase the risk of adenocarcinoma of the esophagus: Gastric reflux. […] The following protective factors may decrease the risk of adenocarcinoma of the esophagus: Chemoprevention with nonsteroidal anti-inflammatory drugs. […] Radiofrequency ablation of the esophagus. […] Cancer prevention clinical trials are used to study ways to prevent cancer. […] New ways to prevent esophageal cancer are being studied in clinical trials.
  • #33 Esophageal cancer: epidemiology, pathogenesis and prevention | Nature Reviews Gastroenterology & Hepatology
    https://www.nature.com/articles/ncpgasthep1223
    Esophageal cancer is highly aggressive and is a common cancer both worldwide and in the US. […] Intensive research into risk factors combined with the ability to identify precursor lesions (e.g. squamous dysplasia in esophageal squamous cell carcinoma and Barrett’s esophagus in esophageal adenocarcinoma) has paved the way for studies of chemoprevention for esophageal cancer, some of which have shown promising results. […] Chemoprevention studies in esophageal cancer, both dietary and pharmacologic show promise but need further study.
  • #34 Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/1471-230X-14-101
    With the high incidence and poor prognosis associated with esophageal cancer, cost-effective strategies aimed at preventing esophageal cancer are highly desirable. […] This EAC risk modification observed with physical activity is comparable to the 30-40% risk reduction seen with aspirin/NSAID and statin use. […] Importantly, recreational physical activity, the potentially modifiable component of energy expenditure, was independently associated with reduced risk of esophageal cancer, with a trend towards a dose-response relationship.
  • #35 Esophageal Cancer Prevention and Screening Program
    https://eisenhowerhealth.org/services/oncology/services/cancer-prevention-and-screenings/esophageal-cancer-prevention-and-screening-program
    Eisenhower Lucy Curci Cancer Center now offers prevention and screening services for those who may have an increased risk of developing esophageal cancer. Screening used for both prevention and detection may result in early diagnosis, at a stage when the cancer is more treatable […] Your recommendations may include: Ongoing surveillance Evaluation and diagnosis using our advanced imaging techniques Nutrition and lifestyle changes Genetic testing to determine whether you have a genetic mutation associated with esophageal cancer […] A personalized plan will be developed focusing on prevention, early detection and, if necessary, treatment.
  • #36 Prevention Strategies for Esophageal Cancer—An Expert Review
    https://www.mdpi.com/2072-6694/13/9/2183
    In conclusion, the primary means of prevention for EAC and ESCC is to identify the risk factors and, if present, eliminate them. […] The secondary prevention consists of the detection of precancerous and early cancerous lesions when curative endoscopic treatment is still possible. […] In particular, we believe that in the future, screening programs for ESCC in high-risk patients and surveillance programs in patients with ESCC that has already been treated need to be defined.
  • #37
    https://link.springer.com/article/10.1007/s40471-014-0015-3
    Making a sizeable contribution to worldwide cancer mortality, adenocarcinomas and squamous cell carcinomas of the esophagus appear to be caused largely by environmental factors. […] Prevention strategies targeting these exposures offer a logical foundation for action, although the outcomes of prevention trials have been frustratingly ineffective to date. […] For EAC, it seems prudent to recommend smoking abstinence for everyone and weight loss for overweight or obese people. Control of acid reflux through medical or surgical means, for which observational studies suggest benefits in reducing the risk of EAC, has clinical appeal and brings symptomatic relief. […] In Western countries, population-wide abstinence from smoking and alcohol would reduce ESCC incidence substantiallyperhaps by as much as 7590 %.
  • #38 Esophageal Cancer Risk Factors & Prevention | Banner MD Anderson
    https://www.bannerhealth.com/services/cancer/cancer-type/esophageal-cancer/risk-factors-and-prevention
    The Banner MD Anderson Cancer Center esophageal cancer team is dedicated to helping patients lower their risk for the disease. If you have an increased risk of cancer, talk to your doctor or make an appointment with a Banner MD Anderson specialist to discuss your concerns and options. […] Esophageal cancer prevention isnt always possible, but you can reduce your risk. Banner MD Andersons caring team of experts is here to help. The following lifestyle habits lower your risk of getting esophageal cancer. […] Avoid tobacco and alcohol: Alone, each of these increases your risk of esophageal cancer many times over, and the risk is even greater if used together. Banner MD Anderson has resources to help you quit. […] Maintain a healthy weight: Eating a healthy diet full of fruits and vegetables and having a healthy body weight can limit your risk for this disease. Check out our healthy living resources. […] Treat acid reflux or Barretts esophagus: Medications and sometimes surgery are needed to treat reflux to stop damage to the esophagus. […] Get periodic upper endoscopies: If you have Barretts Esophagus, you should receive more frequent screenings to detect esophageal cancer early.